CVS Health Co. (NYSE:CVS) Shares Sold by Atlas Brown Inc.

Atlas Brown Inc. lessened its holdings in shares of CVS Health Co. (NYSE:CVS) by 9.4% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 4,751 shares of the pharmacy operator’s stock after selling 492 shares during the period. Atlas Brown Inc.’s holdings in CVS Health were worth $213,000 at the end of the most recent quarter.

A number of other institutional investors have also recently made changes to their positions in the business. MidAtlantic Capital Management Inc. acquired a new stake in CVS Health in the 3rd quarter worth approximately $25,000. Ridgewood Investments LLC lifted its stake in shares of CVS Health by 255.7% during the fourth quarter. Ridgewood Investments LLC now owns 626 shares of the pharmacy operator’s stock worth $28,000 after buying an additional 450 shares during the period. Livelsberger Financial Advisory purchased a new stake in shares of CVS Health during the third quarter valued at $31,000. Legacy Investment Solutions LLC acquired a new position in shares of CVS Health in the 3rd quarter valued at $31,000. Finally, Reston Wealth Management LLC acquired a new stake in CVS Health during the 3rd quarter worth about $32,000. Institutional investors and hedge funds own 80.66% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities analysts recently weighed in on the stock. Mizuho reduced their price target on shares of CVS Health from $73.00 to $66.00 and set an “outperform” rating for the company in a research report on Thursday, October 24th. StockNews.com cut shares of CVS Health from a “hold” rating to a “sell” rating in a report on Thursday, November 14th. UBS Group increased their price target on CVS Health from $60.00 to $62.00 and gave the stock a “neutral” rating in a research report on Thursday, November 7th. Cantor Fitzgerald reissued a “neutral” rating and issued a $62.00 price objective on shares of CVS Health in a report on Tuesday, October 1st. Finally, TD Cowen lifted their target price on shares of CVS Health from $73.00 to $80.00 and gave the company a “buy” rating in a report on Monday, November 25th. One equities research analyst has rated the stock with a sell rating, six have given a hold rating and thirteen have issued a buy rating to the company. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $68.71.

CVS Health Trading Up 4.3 %

Shares of NYSE CVS traded up $2.00 during midday trading on Friday, reaching $48.01. 13,614,145 shares of the stock were exchanged, compared to its average volume of 12,717,844. CVS Health Co. has a twelve month low of $43.56 and a twelve month high of $80.75. The stock has a market capitalization of $60.42 billion, a P/E ratio of 12.19, a PEG ratio of 0.85 and a beta of 0.59. The company has a 50 day simple moving average of $51.98 and a 200 day simple moving average of $56.68. The company has a debt-to-equity ratio of 0.80, a quick ratio of 0.59 and a current ratio of 0.80.

CVS Health (NYSE:CVS) last issued its quarterly earnings data on Wednesday, November 6th. The pharmacy operator reported $1.09 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.08 by $0.01. CVS Health had a net margin of 1.36% and a return on equity of 10.72%. The firm had revenue of $95.43 billion for the quarter, compared to analyst estimates of $92.72 billion. During the same period in the previous year, the firm earned $2.21 EPS. CVS Health’s revenue was up 6.3% on a year-over-year basis. As a group, equities analysts expect that CVS Health Co. will post 5.32 earnings per share for the current year.

CVS Health Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Monday, February 3rd. Stockholders of record on Thursday, January 23rd will be given a dividend of $0.665 per share. The ex-dividend date of this dividend is Thursday, January 23rd. This represents a $2.66 annualized dividend and a dividend yield of 5.54%. CVS Health’s dividend payout ratio is currently 67.51%.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.